decisionhealth Newsletters, Part B News - 2017 Issue 6 (June)
Oft-reported drug, injection codes often pass through cleanly
Subscribe or sign in to view the full article.
Article Overview
This article reviews Medicare claims data for commonly reported drug and injection billing codes and summarizes how often those claims were denied in the most recent years analyzed. It is relevant to coders, billers, and reimbursement staff who work with Part B drug claims, Medicare reporting trends, and payment-update-related compliance issues. The article also references a CMS billing update and a modifier requirement associated with certain ESRD-related services.
Why This Topic Matters
Understanding denial trends for commonly billed drug codes can help practices monitor claim performance and focus review efforts on high-denial items. The article also points to a Medicare policy change that may affect how a specific injection code is reported in certain circumstances.
Article Sections
-
Drug Codes
The article presents Medicare denial-rate trends for commonly reported drug and injection billing codes and summarizes overall claim volume and reimbursement patterns.
What You Will Learn
- How Medicare claims denial patterns are trending for frequently reported drug and injection billing codes
- Which general categories of drug claims are discussed in the analysis
- Why a CMS billing update may be relevant to some drug claim reporting
- How overall volume and denial rates are presented for the most-reported drug codes
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle professionals
- Medicare claims specialists
- Compliance staff
Codes Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com